维普中文期刊产品整合服务
33篇 您的检索式:作者名="Kang GD"
    题名 作者 年代 出处 被引量
1Pathogenicity of thermolabile methylene tetrahydrofolate reductase for vascular dementia显示文摘Yoo JH Choi GD Kang SS 2000Arterioscler Thromb Vasc Biol2000,20,:1
2Pathogenicity of thennolabile methylenetetrahydrofolate reductnse for vascular dementia显示文摘You JH Choi GD Kang SS 2000Arterioscler-Thromb-Vasc-Biol2000,20,8:1
3Efficacy and safetyof regorafenib for advanced gastrointestinal stromal tumours af-ter failure of imatinib and sunitinib (GRID): an international,multicentre, randomised, placebo-controlled, phase 3 trial 显示文摘Demetri GD Reichardt P Kang YK 2013Lancet2013,381,9863:1
4Timosaponin AⅢand its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance显示文摘Lim SM Jeong JJ Kang GD 2015Int Immunopharmacol2015,25,2:1
5Thermosensitive poly(organophosphazene) hydrogels for a controlled drug delivery显示文摘Kang GD Cheon SH Khang G 2006Eur J Pharm Biopharm2006,63,3:1
6Pathogenicity of thennolabile methylenetet-rahydrofolate reductase for vascular denmntia显示文摘Yoo JH Choi GD Kang SS 2000Arterioscler Thromb Vasc Biol2000,20,:1
7Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial 显示文摘Demetri GD Reichardt P Kang YK 2013Lancet2013,381,:1
8Efficacy and safetyof regorafenib for advanced gastrointestinal stromal tumours af-ter failure of imatinib and sunitinib (GRID): an international,multicentre, randomised, placebo-controlled, phase 3 trial 显示文摘Demetri GD Reichardt P Kang YK 2013Lancet2013,381,9863:1
9Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinih and sunitinib (GRID): an international, multicentre, randomised, placebo -controlled, phase 3 trial显示文摘Demetri GD Reichardt P Kang YK 2013Lancet2013,381,9863:1
10Pathogenicity of thermolabile methyle- netetrahydrofolate reductase for vascular dementia 显示文摘Yoo JH Choi GD Kang SS 2000Arterioscler Thromb Vasc Bio12000,20,8:1
11Efficacy and safety ofregorafenib for advanced gastrointestinal stmmal tumours after failure ofimatinib and sunitinib(GRID):an international,muhieentre,randomised,placebo-controlled,phase 3 trial显示文摘Demetri GD Reichardt P Yoon-Koo Kang et a1 2013Lancet2013,381,9863:1
12After more than 10 years of Gulf War veteran medical evaluations,what have we learned? 显示文摘Gray GC Gackstetter GD Kang KK 2004Am J Prey Med2004,26,:1
13Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia显示文摘Yoo JH Choi GD Kang SS 2000Arterioscler Thromb Vasc Biol2000,20,8:1
14Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise显示文摘Valdez G Tapia JC Kang H Clemenson Jr GD Gage FH Lichtman JW 0,,:1
15A paradigm for the development and evaluation of novel implant topologies for bone fixation:implant design and fabrication 显示文摘Kang H Long JP UrbielGoldner GD 2012J Biomech2012,45,13:1
16Pathogenicity of thermolabile methyle- netetrahydrofolate reduetase for vascular dementia 显示文摘Yoo JH Choi GD Kang SS 2000Arterioseler Thromb Vase Biol2000,20,8:1
17Effects of poloxamer on the gelation of silk fibroin显示文摘Kang GD Nahm JH Park JS 0,,11:1
18Pathogenicity of thermolabile methylenetetrahydrolate reductase for vascular dementia显示文摘Yoo JH Choi GD Kang SS 0,,:1
19Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID):an international,multicentre,randomised,placebo-controlled,phase 3 trial显示文摘Demetri GD Reichardt P Kang YK GRID study investigators 2013Lancet2013,381,9863:1
20Thermosensitive poly (organophosphazene) hydrogels for a controlled drug delivery 显示文摘Kang GD Cheon SH Khang G 2006Eur J Pharm Biopharm2006,63,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费